Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

Inari Medical, Inc. Stock Research

NARI

65.80USD-0.41(-0.62%)Market Closed
Watchlist

Market Summary

USD65.80-0.41
Market Closed
-0.62%

NARI Alerts

  • 2 major insider sales recently.
  • Big jump in Revenue (Y/Y)
  • Big jump in Earnings (Y/Y)

NARI Stock Price

NARI RSI Chart

NARI Valuation

Market Cap

3.8B

Price/Earnings (Trailing)

-235.74

Price/Sales (Trailing)

8.63

EV/EBITDA

-541.75

Price/Free Cashflow

-11.0K

NARI Price/Sales (Trailing)

NARI Profitability

EBT Margin

-5.87%

Return on Equity

-6.64%

Return on Assets

-5.6%

Free Cashflow Yield

-0.01%

NARI Fundamentals

NARI Revenue

Revenue (TTM)

439.1M

Revenue Y/Y

28.32%

Revenue Q/Q

2.44%

NARI Earnings

Earnings (TTM)

-16.1M

Earnings Y/Y

120.47%

Earnings Q/Q

194%

Price Action

52 Week Range

52.5983.84
(Low)(High)

Last 7 days

2.4%

Last 30 days

-0.2%

Last 90 days

16.8%

Trailing 12 Months

-8.8%

NARI Financial Health

Current Ratio

8.8

NARI Investor Care

Shares Dilution (1Y)

7.68%

Diluted EPS (TTM)

-0.29

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for NARI

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-09-15
Hoffman William
sold
-1,668,500
66.7401
-25,000
-
2023-09-12
Hill, Mitch C.
sold
-441,040
67.8523
-6,500
chief financial officer
2023-09-12
Hill, Mitch C.
acquired
2,970
0.457
6,500
chief financial officer
2023-08-16
Tu Thomas
sold
-1,647,980
66.1149
-24,926
chief medical officer
2023-08-16
Hykes Andrew
sold
-2,424,830
66.1149
-36,676
president and ceo
2023-08-15
Hoffman William
sold
-1,725,540
69.0215
-25,000
-
2023-08-14
Hill, Mitch C.
acquired
2,970
0.457
6,500
chief financial officer
2023-08-14
Hill, Mitch C.
sold
-458,053
70.4697
-6,500
chief financial officer
2023-07-17
Hoffman William
sold
-1,426,910
57.0765
-25,000
-
2023-07-12
Hill, Mitch C.
acquired
2,970
0.457
6,500
chief financial officer

1–10 of 50

Which funds bought or sold NARI recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-09-26
BROOKFIELD Corp /ON/
sold off
-100
-1,437,060
-
-%
2023-09-20
BARCLAYS PLC
added
159
8,259,000
13,996,000
0.01%
2023-08-22
COMERICA BANK
new
-
52,000
52,000
-%
2023-08-22
VIRGINIA RETIREMENT SYSTEMS ET AL
new
-
360,468
360,468
-%
2023-08-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
added
5.65
-17,577
3,418,750
-%
2023-08-21
Affinity Asset Advisors, LLC
sold off
-100
-1,234,800
-
-%
2023-08-21
OSAIC HOLDINGS, INC.
added
36.11
38,002
172,877
-%
2023-08-21
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
added
20.05
665,000
5,766,000
0.06%
2023-08-18
Legato Capital Management LLC
new
-
994,834
994,834
0.14%
2023-08-17
Orion Portfolio Solutions, LLC
reduced
-5.02
-78,179
662,331
0.01%

1–10 of 45

Latest Funds Activity

Are funds buying NARI calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own NARI
No. of Funds

Schedule 13G FIlings of Inari Medical

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 24, 2023
point72 asset management, l.p.
4.9%
2,611,241
SC 13G
Feb 14, 2023
macquarie group ltd
3.38%
1,814,852
SC 13G/A
Feb 14, 2023
alliancebernstein l.p.
4.1%
2,183,673
SC 13G/A
Feb 13, 2023
capital international investors
0.1%
72,099
SC 13G/A
Feb 13, 2023
milder donald b
6.0%
3,225,220
SC 13G/A
Feb 10, 2023
cvf, llc
4.8%
2,591,665
SC 13G/A
Feb 09, 2023
vanguard group inc
8.07%
4,331,429
SC 13G/A
Feb 06, 2023
wellington management group llp
9.20%
4,938,574
SC 13G/A
Jan 26, 2023
blackrock inc.
10.6%
5,671,100
SC 13G/A
Jan 20, 2023
blackrock inc.
10.6%
5,671,100
SC 13G/A

Recent SEC filings of Inari Medical

View All Filings
Date Filed Form Type Document
Sep 22, 2023
8-K
Current Report
Sep 19, 2023
4
Insider Trading
Sep 15, 2023
144
Notice of Insider Sale Intent
Sep 14, 2023
4
Insider Trading
Aug 18, 2023
4
Insider Trading
Aug 18, 2023
4
Insider Trading
Aug 17, 2023
4
Insider Trading
Aug 16, 2023
144/A
144/A
Aug 16, 2023
4
Insider Trading
Aug 15, 2023
144
Notice of Insider Sale Intent

Peers (Alternatives to Inari Medical)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
2.7T
383.9B
-8.29% 25.93%
28.47
7.03
-0.93% -4.89%
2.3T
211.9B
-2.09% 38.56%
32.19
10.99
6.88% -0.52%
1.7T
289.5B
-1.19% 40.58%
27.62
5.81
4.10% -15.36%
1.3T
538.0B
-6.27% 14.57%
98.4
2.39
10.73% 12.62%
MID-CAP
1.5B
9.9B
-21.75% -30.02%
55.62
0.15
24.14% 106.11%
743.7M
246.5M
-12.96% -3.78%
-4.68
3.02
6.65% -174.04%
SMALL-CAP
1.5B
2.2B
-7.08% 18.88%
10.95
0.7
38.20% -10.10%
1.5B
627.1M
-7.75% -17.45%
-1.01
2.35
-0.20% -204.67%
1.1B
56.2M
19.49% -59.94%
-1.33
19.99
40.31% -12.26%
894.8M
543.3M
-14.90% 19.67%
-616.27
1.65
31.74% 78.13%
559.6M
356.8M
-23.26% -34.79%
-1.99
1.57
-23.03% 15.53%
474.5M
1.0B
-17.03% -38.74%
-17.95
0.46
-11.34% -107.10%
376.1M
453.3M
34.00% -73.00%
-0.31
0.83
-16.04% 55.90%
100.2M
13.7M
-13.82% -77.44%
-0.6
7.34
413.65% 52.51%

Inari Medical News

Investor's Business Daily
Inari Medical Reaches 80-Plus Relative Strength Rating Benchmark.
Investor's Business Daily,
18 hours ago
Nasdaq
GuruFocus.com
StreetInsider.com
Investor's Business Daily
Stocks With Rising Relative Strength: Inari Medical.
Investor's Business Daily,
33 days ago
StreetInsider.com
Simply Wall St
Zacks Investment Research

Returns for NARI

Cumulative Returns on NARI

0.9%


3-Year Cumulative Returns

Risks for NARI

What is the probability of a big loss on NARI?

89.8%


Probability that Inari Medical stock will be more than 20% underwater in next one year

70.6%


Probability that Inari Medical stock will be more than 30% underwater in next one year.

30.5%


Probability that Inari Medical stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does NARI drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Inari Medical was unfortunately bought at previous high price.

Drawdowns

Financials for Inari Medical

Income Statement (Last 12 Months)
Income Statement (Last 12 Months)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22018Q4
Revenue6.4%439,147,000412,886,000383,471,000358,918,000335,630,000306,339,000276,984,000242,377,000208,176,000170,115,000139,670,000110,947,00086,457,00071,137,00051,129,00048,594,00040,288,0006,829,000
Gross Profit6.2%387,370,000364,606,000338,965,000319,260,000299,996,000276,238,000252,227,000222,214,000191,825,000155,091,000126,564,00099,387,00076,615,00063,451,00045,218,00042,912,00034,964,0005,548,000
Operating Expenses3.8%409,907,000394,961,000367,064,000339,722,000313,387,000276,189,000241,383,000206,120,000165,814,000133,795,000108,145,00086,794,00070,319,00057,194,00044,417,00042,410,00037,532,00014,688,000
  S&GA Expenses3.9%327,241,000314,811,000292,843,000267,187,000247,458,000217,199,000190,365,000167,292,000134,268,000110,251,00089,746,00072,222,00059,242,00048,165,00037,197,00035,806,00031,212,00010,698,000
  R&D Expenses3.1%82,666,00080,150,00074,221,00072,535,00065,929,00058,990,00051,018,00038,828,00031,546,00023,544,00018,399,00014,572,00011,077,0009,029,0007,220,0006,604,0006,320,0003,990,000
EBITDA100.0%--19,031,000-21,218,000-15,045,000-8,826,0003,672,00014,014,00018,846,00027,801,00018,206,00014,924,0008,457,0002,302,0004,907,000-272,000-288,000-2,944,000-
EBITDA Margin100.0%--0.05-0.06-0.04-0.030.010.050.080.130.110.110.080.030.07-0.01-0.01-0.07-
Interest Expenses-11.1%232,000261,000294,000295,000294,000295,000295,000295,000473,000862,0001,135,0001,298,0001,273,0001,039,000920,000910,000916,000887,000
Earnings Before Taxes49.3%-12,291,000-24,250,000-26,185,000-19,696,000-13,126,000-111,00010,685,00015,989,00025,228,00017,344,00013,789,0009,072,000616,00016,448,000-1,192,000---
EBT Margin100.0%--0.06-0.07-0.05-0.040.000.040.070.120.100.100.060.010.05-0.02-0.02-0.10-
Net Income43.3%-16,084,000-28,356,000-29,267,000-22,362,000-15,013,000-758,0009,840,00015,718,00025,018,00017,146,00013,789,0007,159,0001,029,0003,868,000-1,192,000-2,062,666-3,826,000-10,153,000
Net Income Margin100.0%--0.07-0.08-0.06-0.040.000.040.060.120.100.100.060.010.05-0.02-0.04-0.09-
Free Cashflow100.0%--15,055,000-23,923,000-21,111,000-16,066,000-7,505,00011,841,000-4,456,0009,557,0005,241,000-3,548,000-1,448,000-6,629,000-6,258,666-8,080,000-5,992,000-9,348,000-
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22019Q4
Assets3.6%52550750448848448431229225423521420622445.00
  Current Assets4.5%44542642341141141324522822822120619922039.00
    Cash Equivalents2.3%58.0057.0060.0084.0080.0018793.0081.0091.0010311524.0019524.00
  Inventory6.8%39.0036.0033.0030.0027.0024.0021.0019.0018.0014.0011.007.006.004.00
  Net PPE-0.9%21.0021.0022.0021.0020.0018.0016.0015.0011.007.007.005.004.003.00
Liabilities11.9%89.0080.0087.0073.0070.0065.0072.0058.0032.0021.0014.0014.0040.0030.00
  Current Liabilities20.5%58.0048.0056.0042.0041.0036.0043.0030.0032.0021.0014.0014.0011.009.00
Shareholder's Equity2.1%436427417415414419239234222214200191184-
  Retained Earnings4.2%-46.98-49.07-46.85-41.05-30.90-20.71-17.58-18.69-15.89-19.95-27.42-34.41-40.90-41.21
  Additional Paid-In Capital1.7%4844764634574464402572532382342282262252.00
Shares Outstanding0.3%57.0057.0054.0054.0053.0051.0050.0050.0050.0049.0049.0048.0024.007.00
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22018Q4
Cashflow From Operations186.2%6.00-6.88-13.97-10.22-2.748.0025.009.0020.0011.002.003.00-2.97-2.45-4.94-1.34-7.55-10.89
  Share Based Compensation9.8%36.0032.0029.0026.0031.0028.0025.0023.0011.007.004.002.001.001.001.001.000.000.00
Cashflow From Investing76.2%-29.97-125-195-164-185-102-51.02-100-94.96-77.34-55.44-4.16-3.66-3.81-3.14-4.65-1.80-0.75
Cashflow From Financing-24.7%2.003.001771781771784.005.00-28.6013614415418527.0010.001.000.0027.00

NARI Income Statement

2023-06-30
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)
$ in Thousands
3 Months Ended6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]    
Revenue$ 119,005$ 92,744$ 235,172$ 179,496
Cost of goods sold13,84410,34727,58520,314
Gross profit105,16182,397207,587159,182
Operating expenses    
Research and development21,08518,56943,14934,704
Selling, general and administrative85,58673,156171,286136,888
Total operating expenses106,67191,725214,435171,592
Loss from operations(1,510)(9,328)(6,848)(12,410)
Other income (expense)    
Interest income4,5522148,697264
Interest expense(44)(73)(84)(146)
Other income2625265228
Total other income4,5343938,678346
Income (loss) before income taxes3,024(8,935)1,830(12,064)
Provision for income taxes9391,2521,9631,252
Net income (loss)2,085(10,187)(133)(13,316)
Other comprehensive income (loss)    
Foreign currency translation adjustments(79)(291)(70)(408)
Unrealized loss on available-for-sale debt securities(1,095)(125)(1,960)(373)
Total other comprehensive loss(1,174)(416)(2,030)(781)
Comprehensive income (loss)$ 911$ (10,603)$ (2,163)$ (14,097)
Net income (loss) per share    
Basic (in dollars per share)$ 0.04$ (0.19)$ (0.00)$ (0.26)
Diluted (in dollars per share)$ 0.04$ (0.19)$ (0.00)$ (0.26)
Weighted average common shares used to compute net income (loss) per share    
Basic (in shares)57,207,90253,183,76755,988,73652,075,399
Diluted (in shares)58,496,35053,183,76755,988,73652,075,399

NARI Balance Sheet

2023-06-30
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets  
Cash and cash equivalents$ 57,837$ 60,222
Short-term investments in debt securities279,696266,179
Accounts receivable, net63,12858,611
Inventories, net38,98432,581
Prepaid expenses and other current assets4,9725,312
Total current assets444,617422,905
Property and equipment, net21,06321,655
Operating lease right-of-use assets49,85750,703
Deposits and other assets9,4318,889
Total assets524,968504,152
Current liabilities  
Accounts payable7,2407,659
Payroll-related accruals38,29038,955
Accrued expenses and other current liabilities11,1258,249
Operating lease liabilities, current portion1,5831,311
Total current liabilities58,23856,174
Operating lease liabilities, noncurrent portion31,08530,976
Total liabilities89,32387,150
Commitments and contingencies (Note 7)
Stockholders' equity  
Preferred stock, $0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of June 30, 2023 and December 31, 202200
Common stock, $0.001 par value, 300,000,000 shares authorized as of June 30, 2023 and December 31, 2022; 57,266,455 and 54,021,656 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively5754
Additional paid in capital483,752462,949
Accumulated other comprehensive (loss) income(1,181)849
Accumulated deficit(46,983)(46,850)
Total stockholders' equity435,645417,002
Total liabilities and stockholders' equity$ 524,968$ 504,152

About Inari Medical